Dermatophagoides Pteronyssinus and Dermatophagoides Farinae Allergen Extract. Determination of the Allergenic Potency in Vivo Histamine Equivalent Units (HEP)

Trial Profile

Dermatophagoides Pteronyssinus and Dermatophagoides Farinae Allergen Extract. Determination of the Allergenic Potency in Vivo Histamine Equivalent Units (HEP)

Recruiting
Phase of Trial: Phase II

Latest Information Update: 17 Mar 2017

At a glance

  • Drugs MM 09 (Primary) ; MM 09 (Primary) ; Histamine dihydrochloride
  • Indications Hypersensitivity
  • Focus Pharmacodynamics
  • Sponsors Inmunotek
  • Most Recent Events

    • 10 Mar 2017 Planned End Date changed from 1 Sep 2016 to 1 Feb 2018.
    • 10 Mar 2017 Planned primary completion date changed from 1 Sep 2016 to 1 Dec 2017.
    • 08 Sep 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top